Page last updated: 2024-10-28

lidocaine and Influenza, Human

lidocaine has been researched along with Influenza, Human in 3 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Liu, X1
Zheng, F1
Tian, L1
Li, T1
Zhang, Z1
Ren, Z1
Chen, X1
Chen, W1
Li, K1
Sheng, J1
Kitahara, K1
Nakamura, Y1
Tsuneoka, Y1
Adachi-Akahane, S1
Tanaka, H1
Yamazaki, H1
Takahara, A2
Yamazaki, J1
Ikeda, T1
Sugiyama, A2
Suzuki, S1
Hagiwara, M1
Nozaki, S1

Other Studies

3 other studies available for lidocaine and Influenza, Human

ArticleYear
Lidocaine inhibits influenza a virus replication by up-regulating IFNα4 via TBK1-IRF7 and JNK-AP1 signaling pathways.
    International immunopharmacology, 2023, Volume: 115

    Topics: Animals; Antiviral Agents; COVID-19; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Inf

2023
Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir in vivo and in vitro.
    Cardiovascular toxicology, 2013, Volume: 13, Issue:3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antiviral Agents; Arterial Pressure; Cardiac Pac

2013
Electrophysiological effects of an anti-influenza drug oseltamivir on the guinea-pig atrium: comparison with those of pilsicainide.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:10

    Topics: Animals; Anti-Arrhythmia Agents; Antiviral Agents; Atrial Fibrillation; Atrial Function; Atrial Func

2013